We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
-2.93%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$448M
AUM Growth
-$144M
(-24%)
Cap. Flow
-$96.8M
Cap. Flow
% of AUM
-21.61%
Top 10 Holdings %
Top 10 Hldgs %
35.17%
Holding
168
New
47
Increased
21
Reduced
40
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celestica
CLS
|
+$19M |
| 2 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$13.4M |
| 3 |
Pacira BioSciences
PCRX
|
+$11.2M |
| 4 |
Sunrun
RUN
|
+$6.27M |
| 5 |
SLB Ltd
SLB
|
+$5.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$8.83M |
| 2 |
Iron Mountain
IRM
|
+$8.24M |
| 3 |
Vistra
VST
|
+$6.26M |
| 4 |
Apollo Global Management
APO
|
+$5.38M |
| 5 |
Snowflake
SNOW
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.47% |
| 2 | Industrials | 13.37% |
| 3 | Healthcare | 9.34% |
| 4 | Utilities | 6.52% |
| 5 | Materials | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
FTAI Aviation
FTAI
$21.8B
| $5.47M | 1.22% |
154,000
-112,500
| -42% | -$3.87M |
|
27
Boston Scientific
BSX
$68.5B
| $5.37M | 1.2% |
+101,650
| New | +$5.33M |
|
|
28
CALL
FTAI Aviation
FTAI
$21.8B
| $5.33M | 1.19% |
150,000
| – | – |
|
29
FerroAtlántica
GSM
$628M
| $5.31M | 1.19% |
1,021,000
-9,000
| -0.9% | -$46.7K |
|
30
Roivant Sciences
ROIV
$24.3B
| $5.26M | 1.17% |
450,000
-104,000
| -19% | -$1.18M |
|
31
CALL
iShares Silver Trust
SLV
$27.6B
| $5.08M | 1.14% |
250,000
| – | – |
|
32
ArcBest
ARCB
$3.33B
| $5.07M | 1.13% |
+50,050
| New | +$5.25M |
|
33
Microsoft
MSFT
$2.92T
| $4.9M | 1.09% |
15,500
-7,750
| -33% | -$2.56M |
|
34
Taboola.com
TBLA
$1.37B
| $4.88M | 1.09% |
1,286,500
-721,000
| -36% | -$2.54M |
|
35
Harmonic Inc
HLIT
$1.2B
| $4.61M | 1.03% |
478,500
-385,000
| -45% | -$4.59M |
|
|
36
CALL
Pacira BioSciences
PCRX
$1.05B
| $4.57M | 1.02% |
+149,000
| New | +$5.37M |
|
37
Eos Energy Enterprises
EOSE
$1.22B
| $4.53M | 1.01% |
2,107,500
+1,786,000
| +556% | +$5.35M |
|
38
Stem
STEM
$47.7M
| $4.49M | 1% |
53,000
-17,150
| -24% | -$1.96M |
|
39
Surgery Partners
SGRY
$2.04B
| $4.39M | 0.98% |
150,000
-10,000
| -6% | -$360K |
|
40
Intel
INTC
$435B
| $4.19M | 0.94% |
+118,000
| New | +$4.11M |
|
41
Amazon
AMZN
$2.48T
| $4.13M | 0.92% |
32,500
-38,500
| -54% | -$5.16M |
|
42
MasTec
MTZ
$24.7B
| $4M | 0.89% |
55,520
-800
| -1% | -$79.7K |
|
43
PUT
VanEck Semiconductor ETF
SMH
$63.8B
| $3.62M | 0.81% |
+25,000
| New | +$3.79M |
|
44
Gen Digital
GEN
$16.6B
| $3.59M | 0.8% |
203,000
+100,000
| +97% | +$1.95M |
|
|
EVBG
45
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $3.36M | 0.75% |
+150,000
| New | +$3.87M |
|
46
Uber
UBER
$144B
| $3.22M | 0.72% |
70,000
-70,800
| -50% | -$3.23M |
|
47
Mirum Pharmaceuticals
MIRM
$6.84B
| $3.16M | 0.71% |
+100,000
| New | +$2.74M |
|
48
ServiceNow
NOW
$114B
| $2.79M | 0.62% |
25,000
+8,500
| +52% | +$970K |
|
49
Global X Uranium ETF
URA
$5.41B
| $2.7M | 0.6% |
100,000
-75,000
| -43% | -$1.76M |
|
50
NVIDIA
NVDA
$4.77T
| $2.61M | 0.58% |
60,000
-60,000
| -50% | -$2.69M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Ardsley Advisory Partners held 168 positions worth $448M, down 24% from $592M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ardsley Advisory Partners withdrew a net $96.8M in Q3 2023, closing 54 positions and reducing 40 holdings. Its most notable exit was United Therapeutics, an estimated $8.83M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Ardsley Advisory Partners opened a new position in Celestica worth $22.8M.
- Ardsley Advisory Partners's largest Q3 2023 buy was Celestica: 929,200 shares worth $22.8M.
- Ardsley Advisory Partners added most to XPLR Infrastructure LP in Q3 2023, an estimated $13.4M increase.
- Ardsley Advisory Partners's biggest Q3 2023 reduction was Vistra, cutting an estimated $6.26M.
- Ardsley Advisory Partners fully exited United Therapeutics in Q3 2023, selling an estimated $8.83M.
- Ardsley Advisory Partners's ten largest holdings make up 35% of its $448M portfolio in Q3 2023.
- Ardsley Advisory Partners opened 47 new positions and closed 54 in Q3 2023.
- Ardsley Advisory Partners's portfolio value fell 24% quarter-over-quarter to $448M.
Based on Ardsley Advisory Partners's 13F filing for Q3 2023, filed 14 Nov 2023.